Coherus BioSciences Management to Present at Upcoming Investor Conferences
Coherus BioSciences (Nasdaq: CHRS) announced its participation in three investor conferences in May 2022. The BofA Securities 2022 Healthcare Conference will occur on May 12 at 3:00 p.m. ET, followed by the UBS Global Healthcare Conference on May 24 at 2:00 p.m. ET, and the H.C. Wainwright Global Investment Conference on May 25 at 9:00 a.m. ET. Audio webcasts of each presentation will be available on the Coherus investors’ page, with archived access for 30 days.
- None.
- None.
Insights
Analyzing...
REDWOOD CITY, Calif., May 10, 2022 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), announced today that senior management will present at the following investor conferences in May.
- BofA Securities 2022 Healthcare Conference on Thursday, May 12 at 3:00 p.m. ET
- UBS Global Healthcare Conference on Tuesday, May 24 at 2:00 p.m. ET
- H.C. Wainwright Global Investment Conference on Wednesday, May 25 at 9:00 a.m. ET
Audio webcasts of these presentations will be available on the investors’ page of the Coherus website at http://investors.coherus.com. Please access the website prior to the start of the presentation to ensure a timely connection to the webcast. Each webcast will be archived on the Coherus website for 30 days.
